Subscribe to our RSS Feed
"Levels of BPA in the human body are very low, indicating that BPA is not accumulated in the body and is rapidly eliminated."
World Health Organization (WHO), November 2010
"The current Tolerable Daily Intake (TDI) level for BPA is adequately justified."
German Society for Toxicology, April 2011
"Studies pursued by FDA's National Center for Toxicological Research (NCTR) have shown no effects of BPA from low-dose exposure"
US Food and Drug Administration (FDA) website 2015
"BPA poses no health risk to consumers of any age group at current exposure levels"
EFSA press release January 2015
"The current Tolerable Daily Intake (TDI) level for BPA is adequately justified."
German Society for Toxicology, April 2011
"BPA poses no health risk to consumers of any age group at current exposure levels"
EFSA press release January 2015
"The current Tolerable Daily Intake (TDI) level for BPA is adequately justified."
German Society for Toxicology, April 2011
"BPA poses no health risk to consumers of any age group at current exposure levels"
EFSA press release January 2015

Latest News

  • Industry comments on scientific committee's draft opinion on the safety of the use of BPA in medical devices

    SCENIHR preliminary opinion finds margin of safety for polycarbonate and epoxy resin medical devices. Within the constraints of the available data, SCENIHR generally found that exposure to BPA from all medical applications is low, often in the range of the very low consumer exposures through the diet.

    30 Jan 2014 » Download (PDF, 155.10 kB)
  • Industry further comments on certain aspects of the EFSA draft opinion

    Industry stresses that in its new draft opinion, EFSA did not conclude that BPA causes effects on the liver, kidney and the mammary gland at dose levels relevant to human exposure, but identified these areas to require risk assessment. Additionally it set a new temporary TDI (t-TDI) as a result of a highly conservative approach and not of increased uncertainty. Finally, industry points out that exposure to BPA for consumers remains extremely low and is well below the new t-TDI.

    24 Jan 2014 » Download (PDF, 129.48 kB)
  • Industry comments on study on BPA from Stanford University

    The recent Lathi et al. study from Stanford University is incapable of establishing any causal link between Bisphenol A (BPA) exposure and miscarriage.

    15 Oct 2013 » Download (PDF, 37.12 kB)
  • Recent study finds unmeasurably low levels of BPA in blood

    A recent study funded by the US Environmental Protection Agency (EPA) found that levels of free BPA in blood is unmeasurably low – and far below levels required to activate any reaction of the endocrine system. The study clarifies an ongoing controversy among scientists regarding BPA-blood levels and related internal exposure to BPA.

    15 Oct 2013 » Download (PDF, 231.47 kB)
  • Industry comments on study on BPA published in the journal Pediatrics

    The results of the study recently published in the journal Pediatrics by Eng et al. fail to establish any meaningful connection between BPA and obesity.

    21 Aug 2013 » Download (PDF, 31.32 kB)
  • Industry statement on EFSA public consultation on BPA

    The members of the PC/BPA-group support EFSA’s comprehensive and transparent science based evaluation of BPA and encourage all stakeholders interested in a science-based assessment process to participate, as the final opinion will benefit from this public consultation process.

    25 Jul 2013 » Download (PDF, 147.16 kB)
  • Industry comments on studies presented at Endocrine Society meeting in San Francisco

    In the last annual Endocrine Society meeting in San Francisco, three experimental studies on BPA were discussed. These studies are based on artificial design and have severe limitations.

    24 Jun 2013 » Download (PDF, 128.88 kB)
  • Industry responds to recent INRA study on BPA

    In a new study by the French National Institute for Agricultural Research (INRA),  BPA in a highly concentrated ethanol was applied to anesthetised dogs. The design of this study is highly experimental and the mechanism of exposure to BPA is not relevant for humans.

    19 Jun 2013 » Download (PDF, 134.39 kB)
  • Industry comments on study linking BPA to obesity

    The recent study by De-Kun Li et al. on the alleged link between BPA and obesity actually fails to establish any causal link.  Researchers measured BPA exposure via single spot urine sample only after obesity had already developed. Therefore, the study does not provide any insights into the cause of the obesity.

    14 Jun 2013 » Download (PDF, 88.08 kB)
  • Industry submits complaint on French law banning BPA from food contact materials

    On 26 March 2013, the PC/BPA Group of PlasticsEurope submitted a complaint to the European Commission following the adoption by France of law n°2012-1442 in December 2012 banning the use of BPA in food contact materials.

    12 Jun 2013 » Download (PDF, 217.39 kB)